Adalberto Miranda-Filho1,2, Marion Piñeros2, Isabelle Soerjomataram2, Isabelle Deltour3, Freddie Bray2. 1. National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. 2. Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. 3. Section of Environment and Radiation, International Agency for Research on Cancer, Lyon, France.
Abstract
Background: Cancers of the brain and CNS constitute a group of rare and heterogeneous tumors. Increasing incidence in Western populations has been linked to improvements in diagnostic technology, although interpretation is hampered by changes in diagnosis and reporting. The present study examines geographic and temporal variations in incidence rates of brain and CNS cancers worldwide. Methods: Data from successive volumes of Cancer Incidence in Five Continents were used, including 96 registries in 39 countries. We used Joinpoint regression to estimate the average annual percentage change and its 95% CI. Results: Globally, a large variability in the magnitude of the diagnosis of new cases of brain and CNS cancer was found, with a 5-fold difference between the highest rates (mainly in Europe) and the lowest (mainly in Asia). Increasing rates of brain and CNS cancer were found in South America, namely in Ecuador, Brazil, and Colombia; in eastern Europe (Czech Republic and Russia), in southern Europe (Slovenia), and in the 3 Baltic countries. Trends were similar between sexes, although decreasing trends in men and women were seen in Japan and New Zealand. Conclusions: Important regional variations in brain and CNS cancers exist, and given an increasing burden and risk worldwide, there is a need for further etiological research that focuses on the elucidation of environmental risk. The trends are sufficiently complex and diffuse, however, to warrant a cautious approach to interpretation.
Background: Cancers of the brain and CNS constitute a group of rare and heterogeneous tumors. Increasing incidence in Western populations has been linked to improvements in diagnostic technology, although interpretation is hampered by changes in diagnosis and reporting. The present study examines geographic and temporal variations in incidence rates of brain and CNS cancers worldwide. Methods: Data from successive volumes of Cancer Incidence in Five Continents were used, including 96 registries in 39 countries. We used Joinpoint regression to estimate the average annual percentage change and its 95% CI. Results: Globally, a large variability in the magnitude of the diagnosis of new cases of brain and CNS cancer was found, with a 5-fold difference between the highest rates (mainly in Europe) and the lowest (mainly in Asia). Increasing rates of brain and CNS cancer were found in South America, namely in Ecuador, Brazil, and Colombia; in eastern Europe (Czech Republic and Russia), in southern Europe (Slovenia), and in the 3 Baltic countries. Trends were similar between sexes, although decreasing trends in men and women were seen in Japan and New Zealand. Conclusions: Important regional variations in brain and CNS cancers exist, and given an increasing burden and risk worldwide, there is a need for further etiological research that focuses on the elucidation of environmental risk. The trends are sufficiently complex and diffuse, however, to warrant a cautious approach to interpretation.
Authors: C Wesseling; A Aragón; L Castillo; M Corriols; F Chaverri; E de la Cruz; M Keifer; P Monge; T J Partanen; C Ruepert; B van Wendel de Joode Journal: Int J Occup Environ Health Date: 2001 Oct-Dec
Authors: Victoria Zigmont; Amy Garrett; Jin Peng; Michal Seweryn; Grzegorz A Rempala; Randall Harris; Christopher Holloman; Thomas E Gundersen; Anders Ahlbom; Maria Feychting; Tom Borge Johannesen; Tom Kristian Grimsrud; Judith Schwartzbaum Journal: Nutr Cancer Date: 2015-08-28 Impact factor: 2.900
Authors: Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler Journal: Cancer Date: 2008-10-01 Impact factor: 6.860
Authors: David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison Journal: Acta Neuropathol Date: 2016-05-09 Impact factor: 17.088
Authors: John D Mathews; Anna V Forsythe; Zoe Brady; Martin W Butler; Stacy K Goergen; Graham B Byrnes; Graham G Giles; Anthony B Wallace; Philip R Anderson; Tenniel A Guiver; Paul McGale; Timothy M Cain; James G Dowty; Adrian C Bickerstaffe; Sarah C Darby Journal: BMJ Date: 2013-05-21
Authors: Isabelle Baldi; Lucie De Graaf; Ghislaine Bouvier; Anne Gruber; Hugues Loiseau; Matthieu Meryet-Figuiere; Sarah Rousseau; Pascale Fabbro-Peray; Pierre Lebailly Journal: Cancer Causes Control Date: 2021-04-19 Impact factor: 2.506
Authors: Lindsay A Williams; Aubrey K Hubbard; Michael E Scheurer; Logan G Spector; Jenny N Poynter Journal: Int J Epidemiol Date: 2021-03-03 Impact factor: 7.196
Authors: Pablo Monterroso; Kristin J Moore; Jeannette M Sample; Natali Sorajja; Allison Domingues; Lindsay A Williams Journal: Cancer Epidemiol Date: 2021-12-09 Impact factor: 2.984
Authors: Viviane A O Silva; Marcela N Rosa; Vera Miranda-Gonçalves; Angela M Costa; Aline Tansini; Adriane F Evangelista; Olga Martinho; Adriana C Carloni; Chris Jones; João Paulo Lima; Luiz F Pianowski; Rui Manuel Reis Journal: Invest New Drugs Date: 2018-06-22 Impact factor: 3.850
Authors: Michael Tin Chung Poon; Paul M Brennan; Kai Jin; Cathie L M Sudlow; Jonine D Figueroa Journal: Neuro Oncol Date: 2021-06-01 Impact factor: 12.300
Authors: Hisham F Bahmad; Darine Daher; Abed A Aljamal; Mohamad K Elajami; Kei Shing Oh; Juan Carlos Alvarez Moreno; Ruben Delgado; Richard Suarez; Ana Zaldivar; Roshanak Azimi; Amilcar Castellano; Robert Sackstein; Robert J Poppiti Journal: J Histochem Cytochem Date: 2021-06-24 Impact factor: 2.479
Authors: Elizabeth Cooper; Peter J Choi; William A Denny; Jiney Jose; Mike Dragunow; Thomas I-H Park Journal: Front Oncol Date: 2021-06-01 Impact factor: 6.244